Logo image of MGS.MI

MAGIS SPA/CERRETO GUIDI (MGS.MI) Stock Fundamental Analysis

BIT:MGS - IT0005525347 - Common Stock

11.2 EUR
+0.2 (+1.82%)
Last: 8/21/2025, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to MGS. MGS was compared to 70 industry peers in the Chemicals industry. MGS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MGS is cheap, but on the other hand it scores bad on growth. These ratings could make MGS a good candidate for value investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

MGS had positive earnings in the past year.
MGS had a positive operating cash flow in the past year.
In the past 5 years MGS has always been profitable.
MGS had a positive operating cash flow in 4 of the past 5 years.
MGS.MI Yearly Net Income VS EBIT VS OCF VS FCFMGS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

MGS has a Return On Assets of 10.96%. This is amongst the best in the industry. MGS outperforms 97.18% of its industry peers.
MGS has a better Return On Equity (18.39%) than 94.37% of its industry peers.
MGS has a better Return On Invested Capital (17.04%) than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MGS is significantly above the industry average of 6.58%.
Industry RankSector Rank
ROA 10.96%
ROE 18.39%
ROIC 17.04%
ROA(3y)11.57%
ROA(5y)8.59%
ROE(3y)21.69%
ROE(5y)18.63%
ROIC(3y)18.61%
ROIC(5y)15.14%
MGS.MI Yearly ROA, ROE, ROICMGS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 10.88%, MGS belongs to the top of the industry, outperforming 85.92% of the companies in the same industry.
In the last couple of years the Profit Margin of MGS has grown nicely.
MGS has a Operating Margin of 15.18%. This is amongst the best in the industry. MGS outperforms 84.51% of its industry peers.
MGS's Operating Margin has improved in the last couple of years.
MGS's Gross Margin of 31.87% is in line compared to the rest of the industry. MGS outperforms 50.70% of its industry peers.
In the last couple of years the Gross Margin of MGS has grown nicely.
Industry RankSector Rank
OM 15.18%
PM (TTM) 10.88%
GM 31.87%
OM growth 3Y18.76%
OM growth 5YN/A
PM growth 3Y27.62%
PM growth 5YN/A
GM growth 3Y5.65%
GM growth 5YN/A
MGS.MI Yearly Profit, Operating, Gross MarginsMGS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MGS is creating value.
The number of shares outstanding for MGS has been increased compared to 1 year ago.
The debt/assets ratio for MGS has been reduced compared to a year ago.
MGS.MI Yearly Shares OutstandingMGS.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
MGS.MI Yearly Total Debt VS Total AssetsMGS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.68 indicates that MGS is not in any danger for bankruptcy at the moment.
MGS has a better Altman-Z score (3.68) than 73.24% of its industry peers.
The Debt to FCF ratio of MGS is 0.88, which is an excellent value as it means it would take MGS, only 0.88 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.88, MGS belongs to the top of the industry, outperforming 97.18% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that MGS is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.12, MGS belongs to the best of the industry, outperforming 85.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.88
Altman-Z 3.68
ROIC/WACC2.25
WACC7.57%
MGS.MI Yearly LT Debt VS Equity VS FCFMGS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.95 indicates that MGS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.95, MGS is doing good in the industry, outperforming 61.97% of the companies in the same industry.
MGS has a Quick Ratio of 1.31. This is a normal value and indicates that MGS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.31, MGS is in the better half of the industry, outperforming 69.01% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.31
MGS.MI Yearly Current Assets VS Current LiabilitesMGS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.58% over the past year.
MGS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.31% yearly.
The Revenue has been growing slightly by 1.08% in the past year.
MGS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.47% yearly.
EPS 1Y (TTM)5.58%
EPS 3Y8.31%
EPS 5YN/A
EPS Q2Q%10.65%
Revenue 1Y (TTM)1.08%
Revenue growth 3Y4.47%
Revenue growth 5YN/A
Sales Q2Q%0.04%

3.2 Future

MGS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.66% yearly.
Based on estimates for the next years, MGS will show a small growth in Revenue. The Revenue will grow by 1.14% on average per year.
EPS Next Y-40.56%
EPS Next 2Y-20.92%
EPS Next 3YN/A
EPS Next 5Y-5.66%
Revenue Next Year-3.78%
Revenue Next 2Y-0.67%
Revenue Next 3YN/A
Revenue Next 5Y1.14%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MGS.MI Yearly Revenue VS EstimatesMGS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2028 20M 40M 60M 80M
MGS.MI Yearly EPS VS EstimatesMGS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2028 0.5 1 1.5

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.87, the valuation of MGS can be described as very cheap.
MGS's Price/Earnings ratio is rather cheap when compared to the industry. MGS is cheaper than 98.59% of the companies in the same industry.
MGS is valuated cheaply when we compare the Price/Earnings ratio to 27.24, which is the current average of the S&P500 Index.
MGS is valuated reasonably with a Price/Forward Earnings ratio of 11.55.
Based on the Price/Forward Earnings ratio, MGS is valued cheaper than 84.51% of the companies in the same industry.
MGS is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.87
Fwd PE 11.55
MGS.MI Price Earnings VS Forward Price EarningsMGS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MGS is valued cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MGS is valued cheaper than 95.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.38
EV/EBITDA 2.77
MGS.MI Per share dataMGS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

MGS has an outstanding profitability rating, which may justify a higher PE ratio.
MGS's earnings are expected to decrease with -20.92% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.92%
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

MGS has a Yearly Dividend Yield of 8.21%, which is a nice return.
MGS's Dividend Yield is rather good when compared to the industry average which is at 3.15. MGS pays more dividend than 98.59% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, MGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.21%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y-20.92%
EPS Next 3YN/A
MGS.MI Yearly Income VS Free CF VS DividendMGS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 5M -5M

More info and screens

MAGIS SPA/CERRETO GUIDI

BIT:MGS (8/21/2025, 7:00:00 PM)

11.2

+0.2 (+1.82%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.49%
Inst Owner ChangeN/A
Ins Owners50.01%
Ins Owner ChangeN/A
Market Cap65.18M
Analysts84
Price Target16.83 (50.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 8.21%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.59%
PT rev (3m)-9.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-44.19%
EPS NY rev (3m)-44.19%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-10.63%
Revenue NY rev (3m)-10.63%
Valuation
Industry RankSector Rank
PE 6.87
Fwd PE 11.55
P/S 0.82
P/FCF 7.38
P/OCF 4.64
P/B 1.38
P/tB 1.48
EV/EBITDA 2.77
EPS(TTM)1.63
EY14.55%
EPS(NY)0.97
Fwd EY8.66%
FCF(TTM)1.52
FCFY13.56%
OCF(TTM)2.41
OCFY21.55%
SpS13.7
BVpS8.11
TBVpS7.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.96%
ROE 18.39%
ROCE 23.57%
ROIC 17.04%
ROICexc 29.13%
ROICexgc 32.28%
OM 15.18%
PM (TTM) 10.88%
GM 31.87%
FCFM 11.08%
ROA(3y)11.57%
ROA(5y)8.59%
ROE(3y)21.69%
ROE(5y)18.63%
ROIC(3y)18.61%
ROIC(5y)15.14%
ROICexc(3y)28.23%
ROICexc(5y)22.09%
ROICexgc(3y)31.53%
ROICexgc(5y)25.03%
ROCE(3y)25.86%
ROCE(5y)21.1%
ROICexcg growth 3Y18.83%
ROICexcg growth 5YN/A
ROICexc growth 3Y20.46%
ROICexc growth 5YN/A
OM growth 3Y18.76%
OM growth 5YN/A
PM growth 3Y27.62%
PM growth 5YN/A
GM growth 3Y5.65%
GM growth 5YN/A
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.88
Debt/EBITDA 0.36
Cap/Depr 166.56%
Cap/Sales 6.53%
Interest Coverage 250
Cash Conversion 92.19%
Profit Quality 101.82%
Current Ratio 1.95
Quick Ratio 1.31
Altman-Z 3.68
F-Score5
WACC7.57%
ROIC/WACC2.25
Cap/Depr(3y)140.38%
Cap/Depr(5y)159.84%
Cap/Sales(3y)4.96%
Cap/Sales(5y)6.19%
Profit Quality(3y)99.86%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.58%
EPS 3Y8.31%
EPS 5YN/A
EPS Q2Q%10.65%
EPS Next Y-40.56%
EPS Next 2Y-20.92%
EPS Next 3YN/A
EPS Next 5Y-5.66%
Revenue 1Y (TTM)1.08%
Revenue growth 3Y4.47%
Revenue growth 5YN/A
Sales Q2Q%0.04%
Revenue Next Year-3.78%
Revenue Next 2Y-0.67%
Revenue Next 3YN/A
Revenue Next 5Y1.14%
EBIT growth 1Y1.07%
EBIT growth 3Y24.07%
EBIT growth 5YN/A
EBIT Next Year37.95%
EBIT Next 3YN/A
EBIT Next 5Y3.72%
FCF growth 1Y26.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.35%
OCF growth 3YN/A
OCF growth 5YN/A